- Home
- OGN vs GOF Comparison
OGN vs GOF Comparison
Compare OGN & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGN
- GOF
- Stock Information
- Founded
- OGN 1923
- GOF 2006
- Country
- OGN United States
- GOF United States
- Employees
- OGN N/A
- GOF N/A
- Industry
- OGN Biotechnology: Pharmaceutical Preparations
- GOF Finance/Investors Services
- Sector
- OGN Health Care
- GOF Finance
- Exchange
- OGN Nasdaq
- GOF Nasdaq
- Market Cap
- OGN 2.5B
- GOF 2.4B
- IPO Year
- OGN N/A
- GOF N/A
- Fundamental
- Price
- OGN $9.82
- GOF $15.08
- Analyst Decision
- OGN Hold
- GOF
- Analyst Count
- OGN 4
- GOF 0
- Target Price
- OGN $18.00
- GOF N/A
- AVG Volume (30 Days)
- OGN 3.5M
- GOF 789.2K
- Earning Date
- OGN 08-05-2025
- GOF 01-01-0001
- Dividend Yield
- OGN 0.81%
- GOF 15.42%
- EPS Growth
- OGN N/A
- GOF N/A
- EPS
- OGN 2.88
- GOF N/A
- Revenue
- OGN $6,294,000,000.00
- GOF N/A
- Revenue This Year
- OGN N/A
- GOF N/A
- Revenue Next Year
- OGN $1.11
- GOF N/A
- P/E Ratio
- OGN $3.42
- GOF N/A
- Revenue Growth
- OGN N/A
- GOF N/A
- 52 Week Low
- OGN $8.01
- GOF $10.96
- 52 Week High
- OGN $23.10
- GOF $16.76
- Technical
- Relative Strength Index (RSI)
- OGN 48.62
- GOF 66.89
- Support Level
- OGN $9.74
- GOF $14.76
- Resistance Level
- OGN $10.27
- GOF $15.10
- Average True Range (ATR)
- OGN 0.36
- GOF 0.10
- MACD
- OGN -0.00
- GOF 0.03
- Stochastic Oscillator
- OGN 29.78
- GOF 94.79
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.